Advanced ultrasound cannot discern who would benefit from beta-blocker treatment after myocardial infarction

A new study by researchers at Karolinska Institutet and Södersjukhuset shows that advanced ultrasound imaging analyses cannot identify patients who would benefit from beta-blocker treatment after a myocardial infarction. The study, published in the European Heart Journal—Cardiovascular Imaging, is a follow-up to the previous REDUCE-AMI study.